Phosphine

Phosphine

SCHEMBL3672901

P.[Cl-].[Cl-].[Cl-].[Cl-].[Ru+4]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Phosphine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL27852307 0.82
Phosphine SCHEMBL27866322 0.82
Hydrochloric Acid SCHEMBL105888 0.82
Phosphine SCHEMBL542123 0.82
Hydrochloric Acid SCHEMBL2776542 0.67
Ammonia Solution, Strong SCHEMBL5873257 0.67
Phosphine SCHEMBL595812 0.67
Water SCHEMBL21359897 0.67
Water SCHEMBL21404301 0.67
Phosphine SCHEMBL4382169 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904424-B1 THE USE OF A PHOSPHORUS CONTAINING LIGAND AND A CYCLIC ORGANIC LIGAND IN A TRANSITION METAL COMPOUND UMICORE AG & CO KG (DE) 2014-12-10 EP disclosed
US-7671224-B2 Use of a phosphorus containing ligand and a cyclic organic ligand in a transition metal compound UMICORE AG & CO. KG (DE) 2010-03-02 US disclosed
US-20080221345-A1 Use of a Phosphorus Containing Ligand and a Cyclic Organic Ligand in a Transition Metal Compound UMICORE AG & CO KG (DE) 2008-09-11 US disclosed